Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Baygam, GamaSTAN S/D, GamaSTAN, Biogam
Synonyms :
immune globulin IM (IGIM)
Class :
Immune globulins
Brand Name :
Baygam, GamaSTAN S/D, GamaSTAN, Biogam
Synonyms :
immune globulin IM (IGIM)
Class :
Immune globulins
Dosage Forms & Strengths Â
Injectable solution Â
16.5% protein/mL (2-mL, 5-mL single-dose vials)- GamaSTAN Â
15-18% [150-180 mg/mL] (2-mL, 5-mL, 10-mL single-dose vials)- GamaSTAN S/D Â
Indicates a susceptible person who has not had measles before and has not been vaccinated :
0.25
mL/kg
Intramuscular (IM)
Comments: Â
Avoid taking the measles vaccine at the same time. Â
0.1
mL/kg
Intramuscular (IM)
for the contacts of Household and institutional hepatitis A Â
 Persons traveling to areas where hepatitis A is common: Â
Dosing is divided based on the duration of stay to areas where hepatitis A is common Â
For one month stay: 0.1 mL/kg intramuscularly IM  Â
For two months stay: 0.2 mL/kg intramuscularly IM  Â
More than two months stay: 0.2 mL/kg intramuscularly IM every two months Â
For Prophylaxis:
0.6 - 1.2
mL/kg
Intramuscular (IM)
within six days of exposure
Note: take only the varicella-zoster IG (Human) is unavailable 
Dosage Forms & Strengths Â
Injectable solution Â
16.5% protein/mL (2-mL, 5-mL single-dose vials)- GamaSTAN Â
15-18% [150-180 mg/mL] (2-mL, 5-mL, 10-mL single-dose vials)- GamaSTAN S/D Â
Age: 12 months-40 yearsÂ
0.1 mL/kg intramuscularly IM for the contacts of Household and institutional hepatitis A Â
Dosing is divided based on the duration of stay to areas where hepatitis A is common. Â
For one month stay: 0.1 mL/kg intramuscularly IM  Â
For two months stay: 0.2 mL/kg intramuscularly IM  Â
More than two months stay: 0.2 mL/kg intramuscularly IM every two months
Indicates a susceptible person who has not had measles before and has not been vaccinated  :
0.25
mL/kg
Intravenous (IV)
Comments: Â
Avoid taking the measles vaccine at the same time.
For Prophylaxis: the dose of 0.6-1.2 mL/kg IM within six days of exposure  Â
Note: take only the varicella-zoster IG (Human) is unavailable Â
may diminish the therapeutic effect of vaccines
vaccinia immune globulin intravenous (Rx)
may diminish the therapeutic effect of vaccines
may diminish the therapeutic effect of vaccines
may diminish the therapeutic effect of vaccines
may diminish the therapeutic effect of vaccines
measles, mumps, rubella, and varicella vaccine, live (Rx)
may diminish the therapeutic effect of vaccines
measles mumps and rubella vaccine, live
may diminish the therapeutic effect of vaccines
measles, mumps, rubella and varicella vaccine, liveÂ
may decrease the therapeutic effects of vaccine
may enhance the thrombogenic effect of immune globulin
may enhance the thrombogenic effect of immune globulin
poliovirus vaccine, live, trivalent
may diminish the therapeutic effect of vaccines
poliovirus vaccine inactivated
may diminish the therapeutic effect of vaccines
may diminish the therapeutic effect of vaccines
smallpox (vaccinia) vaccine, live
may diminish the therapeutic effect of vaccines
may diminish the therapeutic effect of vaccines
may diminish the therapeutic effect of vaccines
may diminish the therapeutic effect of vaccines
measles, mumps, rubella, and varicella vaccine, live (Rx)
immune globulins decrease the efficacy of live vaccines
measles mumps and rubella vaccine, live
immune globulins decrease the efficacy of live vaccines
immune globulins decrease the efficacy of live vaccines
smallpox (vaccinia) vaccine, live
immune globulins decrease the efficacy of live vaccines
immune globulins decrease the efficacy of live vaccines
measles, mumps, rubella, and varicella vaccine, live (Rx)
they decrease the efficacy of live vaccines
measles mumps and rubella vaccine, live
they decrease the efficacy of live vaccines
Adverse drug reactions Â
Frequency Not Defined Â
Angioedema Â
Anaphylactic reaction Â
Urticaria Â
Local pain at the injection site Â
Post-marketing Reports Â
Injection site pain Â
Nausea Â
Fatigue Â
Headache Â
Pyrexia Â
Injection site inflammation Â
 Â
Â
Pregnancy warnings:    Â
AU TGA pregnancy category: Exempt
US FDA pregnancy category: Not assignedÂ
Lactation:Â
Excreted into human milk is unknownÂ
Pregnancy Categories:      Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester. Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were no enough studies on pregnant women.Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.  Â
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.  Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.  Â
Category N: There is no data available for the drug under this categoryÂ
 Â
Patient Information Leaflet   Â
Generic Name: immune globulin IM (IGIM)Â Â
Why do we use immune globulin IM (IGIM)?Â
immune globulin IM (IGIM) is an Immune Globulin used to help prevent infection after exposure to Measles, Chickenpox (Varicella), Rubella, and Hepatitis A.Â
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
